
Inotek Pharmaceutical announced that its lead candidate, trabodenoson, a drug designed to treat glaucoma, had failed to outperform placebos in …

Inotek Pharmaceuticals has announced the appointment of J. Martin Carroll as the new chairman of the board. Carroll will succeed …
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership

